To improve human health through better understanding the interrelationship of chronic diseases
Collaborative and innovative approaches to education and research into chronic diseases
January 22, 2021
The Worldwide Network for Innovation in Clinical Education and Research (WNICER) congratulates the ATTACC Trial team on the release of interim results that show full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients. The WNICER Network played an integral role in this multinational clinical trial led by Drs. Ryan Zarychanski and Patrick Lawler. WNICER acknowledges the contributions of its members: University Health Network’s Peter Munk Cardiac Centre under the leadership of Drs. Patrick Lawler and Michael Farkouh; University of Chicago; Mayo Clinic; The Brazilian clinical network led by Dr. José Nicolau of University of São Paulo’s InCor Heart Institute; and The Mexican clinical network led by Dr. Jorge Escobedo of the National Autonomous University of Mexico.
See press release below.